CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
12 hedge funds and large institutions have $4.96M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
20% more funds holding
Funds holding: 10 → 12 (+2)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.89M | |
| 2 | +$661K | |
| 3 | +$257K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$24K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$14.1K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$235K | |
| 3 | -$16.7K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$3K |